https://www.diaccurate.com/daily1.0 https://www.diaccurate.com/rd-programs2022-02-15T14:13Znever0.7 https://www.diaccurate.com/media/all-events/asco-annual-meeting-20242023-11-04T17:19Znever https://www.diaccurate.com/company/board-directors/scott-filosi2025-12-10T16:04Zyearly https://www.diaccurate.com/evexta-bio-website-privacy-notice2024-01-25T20:34Znever0.7 https://www.diaccurate.com/homepage2023-07-20T08:47Znever1.0 https://www.diaccurate.com/media/all-press-releases/evexta-bio-reports-progress-towards-clinical-development-rupitasertib2024-04-22T08:59Zyearly https://www.diaccurate.com/media/all-press-releases/evexta-bio-appoints-shawn-m-leland-chairman-board-directors2024-06-19T17:19Zyearly https://www.diaccurate.com/company/board-directors/shawn-m-leland2024-06-20T07:07Zyearly https://www.diaccurate.com/company/leadership-team/Martin-Olivo2025-12-10T16:51Zyearly https://www.diaccurate.com/media/all-press-releases/evexta-bio-appoints-edith-perez-scientific-advisor2024-10-30T08:30Zyearly https://www.diaccurate.com/company/board-directors/philippe-pouletty2022-12-13T18:13Znever https://www.diaccurate.com/alain-chevallier-02025-12-10T16:53Zyearly https://www.diaccurate.com/company/leadership-team/dominique-bridon2023-11-03T17:23Znever https://www.diaccurate.com/company/leadership-team/cecile-bougeret2023-11-04T17:30Znever https://www.diaccurate.com/company/leadership-team/Vincent-Dagommer2026-01-30T20:20Zmonthly https://www.diaccurate.com/company/innovative-clinical-stage-biotech-company2026-01-30T20:48Zweekly0.7 https://www.diaccurate.com/legal-notice2026-01-16T13:51Zmonthly0.3 https://www.diaccurate.com/rd-programs/pipeline-overview2023-11-06T16:15Znever0.7 https://www.diaccurate.com/media/all-press-releases/diaccurate-acquires-biokinesis-create-sole-class-biotech-player-oncology2022-02-15T14:13Znever https://www.diaccurate.com/network-excellence2023-11-04T17:26Znever0.7 https://www.diaccurate.com/media/all-press-releases2022-02-15T14:13Znever0.7 https://www.diaccurate.com/join-our-team2023-11-04T17:42Znever0.7 https://www.diaccurate.com/location2022-02-15T14:13Znever0.7 https://www.diaccurate.com/evexta-bio-cookies-notice2024-02-19T12:40Zyearly0.3 https://www.diaccurate.com/company/leadership-team2023-11-04T18:16Znever0.7 https://www.diaccurate.com/rd-programs/evx020-first-class-kif20a-inhibitor-next-generation-adc-payload2026-01-24T15:04Zweekly0.7 https://www.diaccurate.com/company/leadership-team/EDITH-PEREZ2025-12-10T16:43Zyearly https://www.diaccurate.com/company/scientific-advisory-board/paolo-parini2022-02-15T14:13Znever https://www.diaccurate.com/company/board-directors/dominique-carouge2022-12-14T15:58Znever https://www.diaccurate.com/media/media-hub/philippe-pouletty-explains-discovery-diaccurate-bfm-business-show-french2022-02-15T14:13Znever https://www.diaccurate.com/company/board-directors2023-11-04T18:17Znever0.7 https://www.diaccurate.com/company/board-directors/matthias-mullenbeck2022-12-14T15:56Znever https://www.diaccurate.com/rd-programs/rupitasertib2026-01-24T15:12Zweekly0.7 https://www.diaccurate.com/media/all-press-releases/diaccurate-acquires-clinical-stage-sole-class-targeted-cancer-therapy2022-02-15T14:13Znever https://www.diaccurate.com/media/media-hub/merck-kgaa-entrusts-secretive-startup-mid-stage-cancer-drug-targeting-master2022-02-15T14:13Znever https://www.diaccurate.com/media/media-hub/diaccurate-adds-merck-pam-inhibitor-oncologyimmunology-pipeline2022-02-15T14:13Znever https://www.diaccurate.com/alain-chevallier2025-12-10T16:01Zyearly https://www.diaccurate.com/media/all-press-releases/diaccurate-receives-support-bpifrance-conduct-its-diacc2020-program2023-01-05T07:00Znever https://www.diaccurate.com/media/all-press-releases/diaccurate-announces-updated-data-its-novel-pam-pathway-inhibitor2023-04-18T12:42Znever https://www.diaccurate.com/company/leadership-team/scott-filosi2025-12-10T16:21Zyearly